Register entry

Oyster Point Pharma, Inc.

Data as of · How to read this entry

Registered sites
0
Active NDC listings
2
Live patents
12
Countries
0
Catalogue

Drug listings by form and route

2

2 active NDC listings: 2 human prescription drug. By marketing category: NDA 2.

Dosage formNDCs
solution/ drops1
spray1
RouteNDCs
nasal1
ophthalmic1
Labeller name on the listingNDCs
oyster point pharma, inc.2
Exclusivity

Patents and exclusivities

12
PatentProductCoversExpiry
10456396TYRVAYAvarenicline tartrateproductOct 2035
11224598TYRVAYAvarenicline tartrateuseOct 2035
11903941TYRVAYAvarenicline tartrateuseOct 2035
11903942TYRVAYAvarenicline tartrateproductOct 2035
11903943TYRVAYAvarenicline tartrateuseOct 2035
11911380TYRVAYAvarenicline tartrateuseOct 2035
12576080TYRVAYAvarenicline tartrateuseOct 2035
12653824TYRVAYAvarenicline tartrateproductOct 2035
9504644TYRVAYAvarenicline tartrateuseOct 2035
9504645TYRVAYAvarenicline tartrateproductOct 2035
9532944TYRVAYAvarenicline tartrateuseOct 2035
9597284TYRVAYAvarenicline tartrateuseOct 2035
Catalogue

Marketed products

2
BrandGeneric nameForm / routeNDC
Ryzumviphentolamine mesylatesolution/ drops, ophthalmic83368-075NDA
Tyrvayavareniclinespray, nasal73521-030NDA
Enquiry

Common questions

Is Oyster Point Pharma, Inc. FDA approved?
Oyster Point Pharma, Inc. holds no registered establishment of its own; 2 drug products are listed under its name in the National Drug Code Directory, made at sites registered to other firms.
What drugs does Oyster Point Pharma, Inc. make?
2 products are listed under Oyster Point Pharma, Inc. in the openFDA NDC Directory, most often as solution/ drops; spray. The full breakdown by dosage form and route is above. A listing count is not a sales figure.

Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.